Merrimack Pharmaceuticals extends losses By: MarketMinute.com Stock News June 20, 2014 at 20:18 PM EDT Merrimack Pharmaceuticals Inc. (Nasdaq: MACK) extended its losses by falling 89 cents to close at $7.00.